Alternative nicotine delivery systems: current evidence

Česká verze

Authors: J. Malinovská ¹ ; M. Lustigová ² ; M. Koželuhová ¹ ; V. Puchnerová ³ ; J. Urbanová ¹ ; O. Hloch ¹ ; S. Pálová ¹ ; L. Rozsíval ¹; J. Brož ¹
Authors place of work: Interní klinika 2. LF UK a FN Motol, Praha ¹; Přírodovědecká fakulta UK, Praha ²; Kardiologická klinika, 2. LF UK a FN Motol, Praha ³; Interní klinika, 3. LF UK a FN Královské Vinohrady, Praha ⁴
Published in the journal: Epidemiol. Mikrobiol. Imunol. 74, 2025, č. 3, s. 175-179
Category: Souhrnná sdělení
doi: https://doi.org/10.61568/emi/11-6568/20250808/141317

Summary

Alternative nicotine delivery products (ANDS) have gained popularity in recent years. Their potentially lower harm compared to traditional cigarettes and the possibility of using them as part of a harm-reduction strategy in tobacco addiction treatment have been discussed. Current epidemiological trends show a gradual increase in ANDS use by the general population, especially among adolescents and young adults, but also among non-smokers. The most comprehensive evidence regarding health effects is available for e-cigarettes, which suggests that their use does not increase cardiovascular risk, except for hypertension, compared to non-smokers, and reduces the risk of respiratory diseases compared to smoking traditional cigarettes; however, long-term data are lacking for older individuals. In the case of heated tobacco products, there is not enough reliable evidence on health risks compared to current smokers or non-smokers, while concerns remain about the potential toxicity of substances found in these products but absent in cigarette smoke. For nicotine pouches, there is a lack of reliable evidence on long-term effects. Electronic cigarettes are used as a smoking cessation tool in some countries, such as the UK. Existing evidence leans towards the potential use of e-cigarettes as a harm-reduction strategy, although there is currently no global consensus on their role in tobacco addiction treatment. Complete cessation of all tobacco and nicotine products remains the primary recommended approach.

Keywords:

toxicity – Electronic cigarettes – smoking cessation – nicotine pouches – heated tobacco

Zdroje

Kunze U, Schmeiser-Rieder A, Schoberberger R. Prevention of lung cancer by long-term use of alternative nicotine delivery systems? European Journal of Cancer, 1999;35(2):195–196.
Russell MA. The future of nicotine replacement. Br J Addict, 1999;86(5):653–658.
McMillen RC, Gottlieb MA, Shaefer RM, et al. Trends in Electronic Cigarette Use Among U.S. Adults: Use is Increasing in Both Smokers and Nonsmokers. Nicotine & Tobacco Research, 2015;17(10):1195–1202.
Liu X, Lugo A, Spizzichino L, et al. Heat-not-burn tobacco products: concerns from the Italian experience. Tobacco Control, 2019;28(1):113–114.
Abrams DB, Glasser AM, Pearson JL, et al. Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. Annu Rev Public Health, 2018;39 : 193–213.
Banks E, Yazidjoglou A, Brown S, et al. Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. Med J Aust, 2023;218(6):267–275.
Ghazi S, Song MA, El-Hellani A. A scoping review of the toxicity and health impact of IQOS. Tob Induc Dis, 2024;22 : 10.18332/ tid/188867. [8] WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: WHO; 2021. Licence: CC BY-NC-SA 3.0 IGO.054054.
WHO global report on trends in prevalence of tobacco use 2000–2030. Geneva: WHO; 2024. Licence: CC BY-NC-SA 3.0 IGO.
Tattan-Birch H, Brown J, Shahab L, et al. Trends in vaping and smoking following the rise of disposable e-cigarettes: a repeat cross-sectional study in England between 2016 and 2023. The Lancet Regional Health –⁠ Europe, 2024;42 : 100924.
Action on Smoking and Health (ASH). Use of e-cigarettes (vapes) among adults in Great Britain. 2024. [cit. 2025-03-09] Available at: https://ash.org.uk/uploads/Use-of-vapes-among-adults-in-Great-Britain-2024.pdf.
Jackson SE, Cox S, Shahab L, Brown J. Trends and patterns of dual use of combustible tobacco and e-cigarettes among adults in England: A population study, 2016–2024. Addiction, 2025. doi: 10.1111/add.16734.
Erhabor J, Boakye E, Obisesan O, et al. E-Cigarette Use Among US Adults in the 2021 Behavioral Risk Factor Surveillance System Survey. JAMA Network Open, 2023;6(11): e2340859. doi: 10.1001/jamanetworkopen.2023.40859.
Mattingly DT, Hart JL. Trends in Current Electronic Cigarette Use Among Youths by Age, Sex, and Race and Ethnicity. JAMA Network Open, 2024;7(2):e2354872.
Walker N, Parag V, Wong SF et al. Use of e-cigarettes and smoked tobacco in youth aged 14–15 years in New Zealand: findings from repeated cross-sectional studies (2014–19). The Lancet Pu blic Health, 2020;5(4):e204–e212.
Greenhill R, Dawkins L, Notley C et al. Adolescent Awareness and Use of Electronic Cigarettes: A Review of Emerging Trends and Findings. The Journal of Adolescent Health, 2016;59(6):612 –⁠ 619.
O’Brien D, Long J, Quigley J, et al. Association between electronic cigarette use and tobacco cigarette smoking initiation in adolescents: a systematic review and meta-analysis. BMC Public Health, 2021;21(1):954.
Sreeramareddy CT, Acharya K, Manoharan A. Electronic cigarettes use and ‘dual use’ among the youth in 75 countries: estimates from Global Youth Tobacco Surveys (2014–2019). Scienti fic Reports, 2022;12(1):20967.
Action on Smoking and Health (ASH). Use of e-cigarettes (vapes) among young people in Great Britain. 2024. [cit. 2025-0309] Available at: https://ash.org.uk/uploads/Use-of-vapes-among-young-people-in-Great-Britain-2024.pdf.
Jamal A, Park-Lee E, Birdsey J, et al. Tobacco Product Use Among Middle and High School Students –⁠ National Youth Tobacco Survey, United States, 2024. MMWR Morb Mortal Wkly Rep, 2024;73 : 917–924. doi: 10.15585/mmwr.mm7341a2.
Dvořáková Z, Chomynová P. Národní výzkum užívání návykových látek 2023. Zaostřeno, 2024;10(1):1–32.
Hajat C, Stein E, Shantikumar S, et al. A scoping review of studies on the health impact of electronic nicotine delivery systems. In tern Emerg Med, 2022;17(1):241–268.
Okut H, Vindhyal MR, Ablah E. Hypertension and Cardiovascular Diseases among Electronic and Combustible Cigarette Users. Kans J Med, 2022;15 : 226–230.
St Helen G, Jacob Iii P, Nardone N, Benowitz NL. IQOS: examination of Philip Morris International’s claim of reduced exposure. Tob Control, 2018;27(Suppl 1):s30–s36.
Grandolfo E, Ogden H, Fearon IM, et al. Tobacco-Free Nicotine Pouches and Their Potential Contribution to Tobacco Harm Reduction: A Scoping Review. Cureus, 2024;16(2): e54228. doi: 10.7759/cureus.54228.
Lee PN, Fry JS, Ljung T. Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000. BMC Public Health, 2022;22(1):1025.
Kent JT, Mok G, Austin E. Nicotine Toxicity From Repeat Use of Nicotine Pouches. Nicotine Tob Res, 2024;111.
Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev, 2025;1:CD010216. doi: 10.1002/14651858.CD010216.pub9.
Tattan-Birch H, Hartmann-Boyce J, Kock L, et al. Heated tobacco products for smoking cessation and reducing smoking prevalence. Cochrane Database Syst Rev, 2022;1(1):CD013790.
WHO clinical treatment guideline for tobacco cessation in adults. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO.
WHO. Electronic cigarettes: call to action. Geneva: World Health Organization; 2023. [cit. 2024-12-23]. Available at: https://www. who.int/publications/m/item/electronic-cigarettes---call-to-action (Accessed 23 December 2024).
McEwen A, McRobbie J, Ross L, Soar K. Vaping: a guide for health and social care professionals. National Centre for Smoking Cessation and Training (NCSCT); 2023. Version 3. Date of last modification: November 2023. ISBN 978-1-915481-00-9.